Phase II Clinical Development of New Drugs (Hardcover, 1st ed. 2017)

This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.

General

Imprint:	Springer Verlag, Singapore
Country of origin:	Singapore
Series:	ICSA Book Series in Statistics
Release date:	April 2017
First published:	2017
Authors:	Naitee Ting • Ding-Geng Chen • Shuyen Ho • Joseph C. Cappelleri
Dimensions:	235 x 155 x 16mm (L x W x T)
Format:	Hardcover
Pages:	241
Edition:	1st ed. 2017
ISBN-13:	978-981-10-4192-1
Categories:	Books > Science & Mathematics > Mathematics > Probability & statistics Books > Business & Economics > Business & management > Management & management techniques > General Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN:	981-10-4192-X
Barcode:	9789811041921

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!